Skip to main content
. 2022 Jan 8;14(2):308. doi: 10.3390/cancers14020308

Figure 4.

Figure 4

Kaplan–Meier plots of PFS by combined CD163+ TAM marker based on high vs. low average number of communicating CD163+ cells and high vs. low median NND. (A) by four combinations of low/high average number of communicating CD163+ cells and low/high median cancer-to-CD163+ NND; (B) by combined CD163 marker with 3 categories: (1) low average number of communicating CD163+ cells and high median cancer-to-CD163+ NND; (2) low average number of communicating CD163+ cells and low median cancer-to-CD163+ NND; (3) high average number of communicating CD163+ cells and any median cancer-to-CD163+ NND.